Table of Contents
ImmunoGen, Inc. (IMGN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary ImmunoGen, Inc. (ImmunoGen) is a biopharmaceutical company engaged in developing anticancer therapeutics. The company develops product candidates that utilize its proparietary Targeted Antibody Payload (TAP) technology. ImmunoGen's most advanced wholly owned product candidate lorvotuzumab mertansine (IMGN901), a TAP compound used as a ...More »
The Largest Collection of Market Research Reports
From +200,000 authoritative sources
Talk to Alison
00 1 718 618 48 97
This report provides data on the therapeutic development for Type 2 Diabetes, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
Rheumatoid Arthritis - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Rheumatoid Arthritis - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This ...
This report provides information on the therapeutic development for Breast Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...
Reportlinker.com © Copyright 2013. All rights reserved.